Clinical Trial: A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics

U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260500) titled 'A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics' on Nov. 21.

Brief Summary: This study will take place at multiple sites and is divided into three phases:an initial 4-week getting-to-know-you phase,a 26-week main phase where participants receive medication,and a 4-week follow-up phase.Participants will be divided into three groups:two will receive different doses of PEG-rhGH Injection,and the third will receive hGH Injection.The goal is to determine which medication works best.

Study Start Date: Nov. 11

Study Type: INTERVENTIONAL

Condition: Short Sta...